Drug Database
DE

delivery technology (CEFORM EA / CEFORM RA / CEFORM)

✓ Approved

Bausch Health Companies Inc. · 治疗药物

什么是 delivery technology?

delivery technology 是一种治疗药物,由Bausch Health Companies Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名CEFORM EA, CEFORM RA, CEFORM
公司Bausch Health Companies Inc.
给药途径Oral (PO)
状态Approved

治疗适应症

delivery technology 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresOral appliance application✓ Approved

相关研究文献

PubMedMethods in molecular biology (Clifton, N.J.)2026-11-19

The Transformative Role of Artificial Intelligence in Wearable Health Monitoring: Applications in Diagnosis, Therapy, and Rehabilitation.

Shen Xiangru X, Luo Xuefeng X, Sun Yinsong Y, Zhu Zhenglin Z et al.

This chapter explores the transformative impact of artificial intelligence (AI)-augmented wearable technology in dynamic health monitoring across diagnosis, treatment, and rehabilitation. Innovations include real-time cardiovascular disease detection, AI-driven continuous glucose monitoring for diabetes, and neurological disorder tracking using flexible electroencephalograph (EEG) sensors. Therapeutic advances feature smart drug-delivery patches responsive to biomarkers, remote intervention systems, and surgical tools like augmented reality (AR) navigation. Rehabilitation breakthroughs encompass wearables for motor recovery, cardiopulmonary optimization, and neurorehabilitation using brain-computer interfaces. Future progress hinges on multifunctional hardware, federated learning for privacy, explainable AI, and standardized regulations.

PMID 43052671
阅读全文 →
PubMedBMC health services research2026-11-19

Multidisciplinary perspectives on digital healthcare for people with disabilities: a qualitative study using a role-centered matrix approach.

Kim Jae-Hak JH, Kim Kyu-Min KM

People with disabilities experience poorer health outcomes than the general population, much of which is attributed to how services are configured rather than to impairment itself. Digital healthcare may help reconfigure service delivery, but its benefits cannot be assumed to translate directly to this population. Little is known about how professionals involved in delivering such services perceive their roles and feasible forms of collaboration, particularly across different disciplines. This qualitative interview study involved 20 professionals who took part in semi-structured interviews between February and April 2025. The participants represented five fields: medicine, nursing, and clinical psychology; rehabilitation therapy; physical activity and health promotion; social welfare; and health information and assistive technology. Participants had at least 10 years of experience in providing services to people with disabilities. Ten service domains identified through a preparatory literature review formed the 10 questions of the interview guide and the columns of a role-centered matrix, with professional roles forming the rows. Transcripts were analyzed using the framework method, with the matrix used for charting. People with disabilities were not involved as participants, advisers, or members of the research team. Participants broadly agreed on the types of information the service should contain and identified public health centers and disability welfare centers as key delivery settings. However, they differed on who should hold the record and the extent to which access should be provided, ranging from public health centers alone to private institutions providing services. A recurring division concerned whether the provision should be designed specifically for people with disabilities or incorporated into systems serving the broader population. Within this panel, these positions were largely consistent with the information needs and perspectives of each discipline and with the settings in which the professionals worked. The findings provide an expert-derived conceptual model rather than a definitive service specification. Two unresolved issues are particularly important for the intended users: accommodating variation within the population and exercising access rights when capacity to consent is in question. Validation and co-design with people with lived experience of disability are necessary next steps.

PMID 43053045
阅读全文 →
PubMedNature nanotechnology2026-11-19

An extracellular contractile injection system for receptor-mediated protein delivery into plant cells.

Legendre Mark G MG, Muchenje Kimberley T KT, Heredia Andrés A, Colee Clair C et al.

Protein delivery into plant cells remains a major barrier in plant biotechnology. The Photorhabdus virulence cassette (PVC) is an extracellular contractile injection system, a phage tail-like bacterial nanomachine that naturally delivers proteins into insect host cells. Here we retargeted PVCs to plants by engineering their tail fibres to recognize the plant cell surface receptor FLAGELLIN SENSITIVE 2 (FLS2). We designed and characterized a library of FLS2-targeting PVCs and evaluated their ability to deliver native and non-native cargoes, including a fluorescent protein, Cre recombinase and R2 retroelement genome editor. Engineered PVCs delivered Cre into wild-type Arabidopsis thaliana and Nicotiana benthamiana protoplasts and leaf cells with efficiencies up to 16%. Delivery was FLS2 dependent and scaled with receptor abundance, reaching 75% of leaf cells in FLS2-overexpressing Arabidopsis. We further demonstrated the PVC-mediated delivery of R2 protein, resulting in the targeted insertion of a reporter gene into the plant genome and the expression of the integrated gene. This work establishes PVCs as a platform for receptor-mediated protein delivery into plant cells, laying the foundation for targeted and precise plant genetic engineering.

PMID 43052465
阅读全文 →
PubMedNPJ vaccines2026-11-19

Biosynthesis of a nanoscale Vibrio cholerae conjugate vaccine elicits potent immunity through size and receptor effects.

Wang Kangfeng K, Huang Jing J, Li Juntao J, Li Zhenshi Z et al.

Cholera, caused by Vibrio cholerae, remains a significant global health threat, with the O1 serotype being the predominant cause of recent global outbreaks. Although conjugate vaccines against V. cholerae have been developed via chemical methods, the feasibility of applying novel biosynthetic approaches remains uncertain due to the special structure of its O-polysaccharide, which should be recognized by oligosaccharyltransferases. Here, we successfully established an oligosaccharyltransferase PglL-based glycosylation system in an engineered V. cholerae strain to biosynthesize a nanoscale conjugate vaccine, NP-OPSVc(I). The carrier NP was designed by fusing the cholera toxin B subunit (CTB) with a trimer-forming protein (Tri), which could self‑assemble into a nanoparticle during expression. The resulting glycoprotein exhibited high purity, stability, and retained GM1-binding capacity. We found that the size of NP-OPSVc(I) and its GM1 receptor targeting both contribute to a potent humoral immune response, while its efficient delivery is additionally associated with the induction of intestinal mucosal immunity. In mouse models, the NP-OPSVc(I) demonstrated a favorable safety profile and elicited substantially stronger systemic and mucosal immune responses than conventional conjugates, providing great protection against lethal V. cholerae challenge even at a 10‑fold lower dose without requiring an adjuvant. Furthermore, the immune responses were confirmed in non-human primates, supporting its potential for clinical translation. This work not only developed a novel highly effective candidate vaccine against V. cholerae but also significantly expanded the application scope of the PglL-based platform technology, establishing it as a versatile and broadly applicable enzymatic toolkit for vaccine development.

PMID 43052362
阅读全文 →
PubMedInternational journal of obesity (2005)2026-11-19

What is the association between mode of delivery at birth and childhood adiposity? Findings from the Southampton Women's Survey.

Crozier Sarah S, Galani Sevasti S, Barton Sheila J SJ, Harvey Nicholas C NC et al.

Childhood obesity is a major public health concern. Caesarean section (CS) delivery has been linked to increased childhood adiposity; however, the literature is inconsistent. To examine the associations between mode of delivery at birth and adiposity in childhood and whether they differ by type of CS (planned versus emergency). The Southampton Women's Survey recruited 12,583 non-pregnant women between 1998 and 2002 in Southampton, UK. From 3153 women who had liveborn singleton infants followed up after birth, mode of delivery was recorded and adiposity measured at age 4, 6-7 and 8-9 years. Outcome measures were child body mass index (BMI) and fat mass and body fat percentage measured by Dual-Energy X-ray Absorptiometry. Associations were investigated using mixed-effects linear regression models after multiple imputation by chained equations, adjusting for maternal (adiposity, age, education, pre-eclampsia, gestational diabetes, smoking during pregnancy) and child-related confounders (birthweight, sex, gestational age), ascertained using a Directed Acyclic Graph. 16% of the women had an emergency CS, and 8% a planned CS. Adjusted analyses showed that CS (versus vaginal delivery) was associated with increased offspring adiposity, with the magnitude of association increasing with the age of the child. For example, compared to children born vaginally, those born via CS had an average fat mass percentage 0.09 standard deviations (95% CI 0.00, 0.18, p = 0.04) higher and showed a 0.03 standard deviation (95% CI 0.01, 0.06; p = 0.009) greater increase in body fat percentage per year. Emergency CS was associated with increased adiposity compared to assisted vaginal delivery, particularly for BMI and fat mass outcomes. CS-delivered babies had higher childhood BMI, fat mass and body fat percentage. Emergency CS accounted for most CS deliveries and was associated with increased adiposity. The findings support important effects of maternal and early life factors on long-term health outcomes.

PMID 43052426
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Non-Canonical Peptide Self-Assembly for Mitochondria-Specific Cargo Delivery.

Jia Ziyu Z, Wen Jian J, Zhang Shengyi S, Ding Yinghao Y et al.

Targeting mitochondria is a promising strategy for precision tumor therapy, yet ligand-free mitochondrial drug delivery remains challenging. Here, we report a minimalist, intrinsically mitochondria-targeting noncanonical tetrapeptide, X-GNNpY, comprising one glycine, two (S)-2-amino-3-(naphthalen-1-yl)-propanoic acid residues (N), and one phosphorylated tyrosine (pY). Without external targeting ligands, X-GNNpY selectively accumulates in tumor-cell mitochondria through enzyme-instructed self-assembly. Conjugating chlorambucil (CLB) yields CLB-GNNpY, which efficiently redirects CLB to mitochondria. CLB-GNNpY exhibits good cellular selectivity, induces mitochondrial stress and immunogenic cell death, promotes M1-like macrophage polarization, and markedly enhances antitumor phagocytosis. This proof-of-concept study establishes noncanonical peptide self-assembly as a ligand-free supramolecular strategy for mitochondrial drug delivery and immune modulation in tumor therapy.

PMID 43053355
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多delivery technology